Risk stratification in acute coronary syndromes - Does the TIMI risk score work in unselected cases?

QJM: An International Journal of Medicine

Volumn 99, Issue 2, 2006, Pages 81-87

  Soiza, R L ^a   Leslie, S J ^a   Williamson, P ^a   Wai, S ^a   Harrild, K ^b   Peden, N R ^a   Hargreaves, Allister D ^a  

^a NHS FORTH VALLEY   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN;

ACUTE CORONARY SYNDROME; ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CORONARY RISK; DISEASE FREE SURVIVAL; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MAXIMUM LIKELIHOOD METHOD; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RECURRENT DISEASE; REGRESSION ANALYSIS; REVASCULARIZATION; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; STATISTICAL MODEL;

EID: 32244442564     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcl001     Document Type: Article

References (28)

1. The Platelet Receptor inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q wave myocardial infarction. N Engl J Med 1998; 338:1488-97.
2. The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/ IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 1998; 339:436-43.
3. Goodman D. Early-invasive or early conservative management of patients with unstable angina or non-Q-wave myocardial infarction. Adv Ther 2000; 17:45-55.
4. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001; 334:1879-87.
5. Solomon DH, Stone PH, Glynn RJ, et al. Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy. J Am Coll Cardiol 2001; 38:969-76.
6. Solomon DH, Ganz DA, Avorn J, et al. Which patients with unstable angina or non-Q-wave myocardial infarction should have immediate catheterisation? A clinical decision rule for predicting who will fail medical therapy. J Clin Epidemiol 2002; 55:121-8.
7. Fragmin and Fast Revascularisation during InStability in Coronary artery disease (FRISC II) Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomized multicentre study. Lancet 1999; 354:708-15.
8. Boden WE. Interpreting new treatment guidelines for non-ST-segment elevation acute syndromes. Am J Cardiol 2001; 88(suppl.):19K-24K.
9. European network for acute coronary syndrome treatment - ENACT. Eur Heart J 2000; 21:1440-9.
10. Antman EM, Cohen M, Bernink PJLM, et al. The TIMI Risk Score for Unstable Angina/Non-ST Elevation MI. A Method for Prognostication and Therapeutic Decision Making. JAMA 2000; 284:835-42.
11. Morrow DA, Antman EM, Snapinn SM, et al. An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS. Eur Heart J 2002; 23:223-9.
12. Samaha FF, Kimmel SE, Kizer JR, et al. Usefulness of the TIMI Risk Score in predicting both short and long term outcomes in the Veterans Affairs Non-Q-Wave Myocardial Infarction Strategies In-Hospital (VANQWISH) Trial. Am J Cardiol 2002; 90:922-6.
13. Bartholomew BA, Sheps DS, Monroe S, McGorray S, Smith K, Pepine CJ. A population-based evaluation of the thrombolysis in myocardial infarction risk score for unstable angina and non-ST elevation myocardial infarction. Clin Cardiol 2004; 27:74-8.
14. Parmar MKB, Machin D. Survival analysis: A practical approach. Chichester, John Wiley & Son, 1995.
15. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomized, placebo-controlled trial. Lancet 2002; 360:7-22.
16. Steg PG, Goldberg RJ, Gore JM, et al. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol 2002; 90:358-63.
17. Granger CB, Goldberg RJ, Dabbous O, et al. Predictors of hospital mortality in the Global Registry of Acute Coronary Events. Arch Intern Med 2003; 163:2345-53.
18. Baillard C, Boussarar M, Fosse JP, et al. Cardiac troponin I in patients with severe exacerbation of chronic obstructive disease. Intensive Card Med 2003; 29:584-9.
19. Pruszczyk P, Bochowicz A, Torbicki A, et al. Cardiac troponin T monitoring identifies high-risk group of normotensive patients with acute pulmonary embolism. Chest 2003; 123:1947-52.
20. Ammann P, Maggiorini M, Bertel O, et al. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndrome. J Am Coll Cardiol 2003; 41:2004-9.
21. Jernberg T, Stridsberg M, Venge P, Lindahl B. N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am Coll Cardiol 2002; 40:437-45.
22. de Winter RJ, Fischer J, Bholasingh R, et al. C-Reactive protein and cardiac troponin T in risk stratification: Differences in optimal timing of tests early after the onset of chest pain. Clin Chem 2000; 46:1597-603.
23. Bodi VV, Sanchis J, Llacer A, et al. Prognostic markers of non-ST elevation acute coronary syndromes. Rev Esp Cardiol 2003; 56:857-64.
24. Swinburn JM, Stubbs P, Soman P, et al. Independent value of tissue harmonic echocardiography for risk stratification in patients with non-ST-segment elevation acute chest pain. J Am Soc Echocardiogr 2002; 15:1031-7.
25. Jernberg T, Lindahl B, Wallentin L. ST-segment monitoring with continuous 12-lead ECG improves early risk stratification in patients with chest pain and ECG nondiagnostic of acute myocardial infarction. J Am Coll Cardiol 1999; 34:1413-19.
26. Jernberg T, Lindahl B, Wallentin L. The combination of a continuous 12-lead ECG and troponin T; a valuable tool for risk stratification during the first 6 hours in patients with chest pain and a non-diagnostic ECG. Eur Heart J 2000; 21:1403-5.
27. Decker WW, Prina LID, Smars PA, et al. Continuous 12-lead electrocardiographic monitoring in an emergency department chest pain unit: An assessment of potential clinical effect. Ann Emerg Med 2003; 41:342-51.
28. Khot UN, Jia G, Moliterno DJ, et al. Prognostic importance of physical examination for heart failure in non-ST elevation acute coronary syndromes: The enduring value of the Killip classification. JAMA 2003; 290:2174-81.